 |
| |
 |
|
| |
|
|
|
|
|
| |
 |
|
| |
Super Religare Laboratories Limited (Formerly SRL Ranbaxy Ltd.) is one of the leading pathology laboratory network in India, servicing nearly 1550 hospitals/path labs and over 50,000 doctors. SRL along with its subsidiary SRL Diagnostics Private Limited performs over 33,000 tests/day and catered to approximately 4.20 million customers during the nine month period ended December 31, 2010, offering a comprehensive range of over 3,300 diagnostic tests, from the routine to the highly specialized tests. The tests are based on more than 200 technologies covering most known diseases. |
|
| |
SRL provides service in the field of Laboratory Medicine and Clinical Trials in India as well as in our neighboring Asian countries. It uses incisive technology and has a wide ranging test menu covering every conceivable illness including infectious, metabolic, genetic, neoplastic and life style disorders spanning across all
specialties of medicine, at par with the best in the world. |
|
| |
The stringent quality controls and processes, backed by contemporary IT network and an efficient logistics management ensures highest global levels of accuracy of the tests conducted by the SRL labs. SRL realizes the criticality of pathology testing to medical diagnosis and treatment. It is committed to bring quality testing across all segments of the population. |
| |
|
| |
|
|
| |
"Hub & Spoke" arrangement
Our presence extends to national and
international network of laboratories, including
Reference Laboratories, located in Mumbai, Delhi and
Kolkatta and Dubai. We have added 8 laboratories in 2009-10, which is indicative of SRL's ambitious plans. We intend to open new laboratories primarily in markets in which we currently operate, by the end of Fiscal across the SRL system. Achieving a consistency in quality that conforms with SRL's culture of excellence is difficult in laboratories acquired from and managed by individuals and groups with a different and sometimes incompatible philosophy. |
|
| |
|
|
|
|
|
|
